Rapid Development of Graves’ Ophthalmopathy After Treatment With Ipilimumab and Recurrence With Pembrolizumab in a Patient With Previously Treated Graves’ Disease | Zendy

AI Assistant Blog Pricing

Rapid Development of Graves’ Ophthalmopathy After Treatment With Ipilimumab and Recurrence With Pembrolizumab in a Patient With Previously Treated Graves’ Disease

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.